InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,178.80
(
-0.10%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
82.62
(
-1.10%
)
Bitcoin
71,051.93
(
-0.56%
)
Post# of 251866
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119663
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 191437

Saturday, 05/23/2015 1:45:42 PM

Saturday, May 23, 2015 1:45:42 PM

Post# of 251866
Quiz: Why is BXLT’s gene-therapy candidate for hemophilia A about two years behind its gene-therapy candidate for hemophilia B? (Hint: This is not a business decision; the hemophilia-A market is ~4x larger than the hemophilia-B market.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up